SuperworthAVITA Medical profit margin RCEL
Gross, operating and net profit as a share of revenue over the last twelve months, from 2021.
- Net margin, 12 months
- −57.0%
- Operating margin, 12 months
- −46.6%
- Net margin on a year earlier
- +11.9 pts
- Peer median
- 7.8%
Over the twelve months to Jun 30, 2026, AVITA Medical kept −57.0% of its revenue as net profit, with an operating margin of −46.6% and a gross margin of 81.6%.
Five years earlier its net margin was −90.9%.
The median for 10 medical instruments and supplies stocks of a similar size is 7.8%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −67.9% | −59.4% | 82.1% |
| FY2024 | −96.3% | −88.1% | 85.8% |
| FY2023 | −70.6% | −85.1% | 84.5% |
| FY2022 | −77.5% | −79.9% | 82.4% |
| FY2021 | −90.9% | −90.8% | 79.6% |
| FY2021 | −76.1% | −76.1% | 81.5% |
| FY2020 | n/a | n/a | 79.2% |
| FY2019 | n/a | n/a | 76.8% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −57.0% | +11.9 pts | −46.6% | |
| Q1 FY26 | −62.7% | +16.9 pts | −54.6% | |
| Q4 FY25 | −67.9% | +28.4 pts | −59.4% | |
| Q3 FY25 | −67.1% | +28.4 pts | −58.1% | |
| Q2 FY25 | −68.9% | +23.2 pts | −62.4% | |
| Q1 FY25 | −79.6% | +8.8 pts | −71.5% | |
| Q4 FY24 | −96.3% | −25.7 pts | −88.1% | |
| Q3 FY24 | −95.5% | −21.3 pts | −98.1% | |
| Q2 FY24 | −92.0% | −17.3 pts | n/a | |
| Q1 FY24 | −88.4% | −17.8 pts | −98.5% | |
| Q4 FY23 | −70.6% | +6.9 pts | −85.1% | |
| Q3 FY23 | −74.2% | +19.2 pts | −79.9% |
Against its peers
Companies in Medical - Instruments & Supplies nearest AVITA Medical's size, closest first, today.
| Company | Profit margin |
|---|---|
| RCELAVITA Medical | −57.0% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| EMBCEmbecta | 8.6% |
| MOVMovado | 6.0% |
| INFUInfuSystem | 6.0% |
| UTMDUtah Medical Products | 29.0% |
| IRMDIradimed | 26.7% |
| STAAStaar Surgical | 1.1% |
| PDEXPro DEX | 17.6% |
| BVSBioventus | 9.4% |
| Peer median | 7.8% |
Where AVITA Medical ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on AVITA Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.